Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals

Evaluation of the Roche SARS-CoV-2 Rapid Antibody Test in Samples from Vaccinated Individuals

ABSTRACT The study aimed to establish the performance of the SARS-CoV-2 Rapid Antibody Test (IgG and IgM) and the Elecsys Anti-SARS-CoV-2 S assay in vaccinated individuals. A panel of serum samples from Boca Biolistics was utilized to assess antibodies following vaccination, consisting of samples dr...

Full description

Bibliographic Details
Main Authors:	Johannes Hayer, Eva Urlaub
Format:	Article
Language:	English
Published:	American Society for Microbiology 2022-06-01
Series:	Microbiology Spectrum
Subjects:	antibodies neutralizing COVID-19 vaccines immunity immunoassay nucleocapsid protein
Online Access:	https://journals.asm.org/doi/10.1128/spectrum.02709-21

Similar Items

Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
by: Rie Midorikawa, et al.
Published: (2022-05-01)

Anti-spike, Anti-nucleocapsid and Neutralizing Antibodies in SARS-CoV-2 Inpatients and Asymptomatic Individuals
by: Etienne Brochot, et al.
Published: (2020-10-01)

Validation of N Protein Antibodies to Diagnose Previous SARS-CoV-2 Infection in a Large Cohort of Healthcare Workers: Use of Roche Elecsys<sup>®</sup> Immunoassay in the S Protein Vaccination Era
by: Juan Francisco Delgado, et al.
Published: (2023-04-01)

Variation in antibody titers determined by Abbott and Roche Elecsys SARS-CoV-2 assays in vaccinated healthcare workers
by: Miku Nakai, et al.
Published: (2023-06-01)

Performance of the Roche/Snibe electrochemiluminescent anti-SARS-COV-2 spike assays compared to the Roche/Abbott IgG nucleocapsid and Abbott IgM spike assays
by: C.S. Lau, et al.
Published: (2021-11-01)

Five Commercial Immunoassays for SARS-CoV-2 Antibody Determination and Their Comparison and Correlation with the Virus Neutralization Test
by: Václav Šimánek, et al.
Published: (2021-03-01)

Utility of Roche Elecsys anti-SARS-CoV-2 S in ascertaining post-vaccine neutralizing antibodies
by: Javeria Aijaz, et al.
Published: (2023-02-01)

Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
by: Sabine Chapuy-Regaud, et al.
Published: (2021-12-01)

Performance evaluation of an automatic chemiluminescence immune platform for SARS-CoV-2 neutralizing antibody after vaccination in real world
by: Min Li, et al.
Published: (2022-02-01)

Recombinant COVID-19 vaccine based on recombinant RBD/Nucleoprotein and saponin adjuvant induces long-lasting neutralizing antibodies and cellular immunity
by: Amir Ghaemi, et al.
Published: (2022-09-01)

Methods to evaluate the impact of SARS-CoV-2 nucleocapsid mutations on antigen detection by rapid diagnostic tests
by: Bryan C Tieman, et al.
Published: (2022-09-01)

Assessing SARS-CoV-2 Neutralizing Antibodies after BNT162b2 Vaccination and Their Correlation with SARS-CoV-2 IgG Anti-S1, Anti-RBD and Anti-S2 Serological Titers
by: Angélica Ramos, et al.
Published: (2022-01-01)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
by: Steven J. Drews, et al.
Published: (2022-02-01)

The presence of anti–SARS-CoV-2 antibodies does not necessarily reflect efficient neutralization
by: Giuseppe Lippi, et al.
Published: (2022-04-01)

Longer Intervals before Vaccination Increase Spike Antibody Titers in Individuals Previously Infected with SARS-CoV-2
by: Xiuqiong Bi, et al.
Published: (2022-04-01)

Antibody Response to SARS-CoV-2 in the First Batch of COVID-19 Patients in China by a Self-Developed Rapid IgM-IgG Test
by: Yiyi Pu, et al.
Published: (2022-05-01)

Performance Evaluation of RapiSure (EDGC) COVID-19 S1 RBD IgG/Neutralizing Ab Test for the Rapid Detection of SARS-CoV-2 Antibodies
by: Ha Nui Kim, et al.
Published: (2023-02-01)

Review of therapeutic mechanisms and applications based on SARS-CoV-2 neutralizing antibodies
by: Mingtao Liu, et al.
Published: (2023-03-01)

High Prevalence of Undocumented SARS-CoV-2 Infections in the Pediatric Population of the Tyrolean District of Schwaz
by: Teresa Harthaller, et al.
Published: (2022-10-01)

An automated chemiluminescent immunoassay (CLIA) detects SARS-CoV-2 neutralizing antibody levels in COVID-19 patients and vaccinees
by: Binjian Liu, et al.
Published: (2022-02-01)

Rapidly Declining SARS-CoV-2 Antibody Titers within 4 Months after BNT162b2 Vaccination
by: Dong-Ho Jo, et al.
Published: (2021-10-01)

Comparison of Six Serological Immunoassays for the Detection of SARS-CoV-2 Neutralizing Antibody Levels in the Vaccinated Population
by: Hee-Jung Lee, et al.
Published: (2022-04-01)

Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor
by: Sonia Aparecida Andrade, et al.
Published: (2022-07-01)

The Meaning of SARS-CoV-2 Antibodies in a Patient with a Systemic Reaction to the mRNA-1273 SARS-CoV-2 Vaccine after Previous Natural Immunization
by: Lorraine Sazgary, et al.
Published: (2021-06-01)

An update on lateral flow immunoassay for the rapid detection of SARS-CoV-2 antibodies
by: Lucia Spicuzza, et al.
Published: (2023-04-01)

Estimating the Neutralizing Effect and Titer Correlation of Semi-Quantitative Anti-SARS-CoV-2 Antibody Immunoassays
by: Beomki Lee, et al.
Published: (2022-04-01)

Immunoglobulin G antibody response to the Sputnik V vaccine: previous SARS-CoV-2 seropositive individuals may need just one vaccine dose
by: Franklin Claro, et al.
Published: (2021-10-01)

A Multivariant Surrogate Neutralization Assay Identifies Variant-Specific Neutralizing Antibody Profiles in Primary SARS-CoV-2 Omicron Infection
by: David Niklas Springer, et al.
Published: (2023-07-01)

Immunized mice naturally process in silico-derived peptides from the nucleocapsid of SARS-CoV-2
by: Mario Aldair Campos-Ruíz, et al.
Published: (2023-10-01)

Designing a Novel Nano-Vaccine against SARS-CoV-2
by: Ang Gao, et al.
Published: (2020-12-01)

Factors Affecting the Antibody Immunogenicity of Vaccines against SARS-CoV-2: A Focused Review
by: Zhangkai Jason Cheng, et al.
Published: (2021-08-01)

Nucleocapsid Specific Diagnostics for the Detection of Divergent SARS-CoV-2 Variants
by: Ariel Isaacs, et al.
Published: (2022-06-01)

Quantitative SARS-CoV-2 Spike Antibody Response in COVID-19 Patients Using Three Fully Automated Immunoassays and a Surrogate Virus Neutralization Test
by: Yoonjoo Kim, et al.
Published: (2021-08-01)

Detection of Neutralizing Antibodies against SARS-CoV-2 Post-Vaccination in Health Care Workers of a Large Tertiary Hospital in Spain by Using a Rapid Test LFIC and sVNT-ELISA
by: José Tuells, et al.
Published: (2022-03-01)

Structure-based neutralizing mechanisms for SARS-CoV-2 antibodies
by: Qingrui Huang, et al.
Published: (2022-12-01)

Correlation of humoral immune responses to different SARS-CoV-2 antigens with virus neutralizing antibodies and symptomatic severity in a German COVID-19 cohort
by: Alexandra Rockstroh, et al.
Published: (2021-01-01)

Preclinical Establishment of a Divalent Vaccine against SARS-CoV-2
by: Zsofia Hevesi, et al.
Published: (2022-03-01)

Are the new SARS-CoV-2 variants resistant against the vaccine?
by: Mohnad Abdalla, et al.
Published: (2021-10-01)

Breakthrough SARS-CoV-2 Omicron Variant in Individuals Primed with Heterologous Vaccines Enhances Inhibition Performance of Neutralizing Antibody to BA.2 Parental Lineage
by: Jidapa Szekely, et al.
Published: (2023-07-01)

Independent Protection and Influence of the Spike-Specific Antibody Response of SARS-CoV-2 Nucleocapsid Protein (N) in Whole-Virion Vaccines
by: Huijie Yang, et al.
Published: (2023-11-01)